X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs149368-   
Low Rs82265-   
Sales per share (Unadj.) Rs84.1109.3-  
Earnings per share (Unadj.) Rs-18.3-27.6-  
Cash flow per share (Unadj.) Rs-6.7-22.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs83.785.8-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.42.9 47.4%   
Avg P/E ratio x-6.3-11.5 54.9%  
P/CF ratio (eoy) x-17.2-13.9 124.4%  
Price / Book Value ratio x1.43.7 37.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,07453,397 13.2%   
No. of employees `0002.84.3 64.1%   
Total wages/salary Rs m1,4493,351 43.2%   
Avg. sales/employee Rs Th1,874.14,298.8 43.6%   
Avg. wages/employee Rs Th527.0780.6 67.5%   
Avg. net profit/employee Rs Th-407.7-1,083.2 37.6%   
INCOME DATA
Net Sales Rs m5,15418,455 27.9%  
Other income Rs m100129 77.2%   
Total revenues Rs m5,25418,584 28.3%   
Gross profit Rs m-766-3,198 24.0%  
Depreciation Rs m711796 89.3%   
Interest Rs m1,503500 300.7%   
Profit before tax Rs m-2,881-4,365 66.0%   
Minority Interest Rs m11-12 -88.8%   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m17273 6.2%   
Profit after tax Rs m-1,121-4,650 24.1%  
Gross profit margin %-14.9-17.3 85.8%  
Effective tax rate %-0.6-6.2 9.3%   
Net profit margin %-21.8-25.2 86.3%  
BALANCE SHEET DATA
Current assets Rs m3,81013,517 28.2%   
Current liabilities Rs m8,3657,605 110.0%   
Net working cap to sales %-88.432.0 -275.9%  
Current ratio x0.51.8 25.6%  
Inventory Days Days156111 140.4%  
Debtors Days Days67124 54.2%  
Net fixed assets Rs m14,4807,879 183.8%   
Share capital Rs m6186 71.5%   
"Free" reserves Rs m9030-   
Net worth Rs m5,12714,485 35.4%   
Long term debt Rs m5,8325,090 114.6%   
Total assets Rs m19,43327,363 71.0%  
Interest coverage x-0.9-7.7 11.9%   
Debt to equity ratio x1.10.4 323.7%  
Sales to assets ratio x0.30.7 39.3%   
Return on assets %2.0-15.2 -12.9%  
Return on equity %-21.9-32.1 68.1%  
Return on capital %3.6-19.8 -18.4%  
Exports to sales %24.50-   
Imports to sales %10.20-   
Net fx Rs m5970-   
CASH FLOW
From Operations Rs m5991,575 38.0%  
From Investments Rs m-438-484 90.5%  
From Financial Activity Rs m-3034,620 -6.6%  
Net Cashflow Rs m-1415,711 -2.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.07 Rs / ZAR

Compare PANACEA BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: TTK HEALTHCARE  STRIDES PHARMA SCIENCE  JUBILANT LIFE SCIENCES  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Sensex Ends Day in Red, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Share markets in India witnessed most of the selling pressure during closing hours yesterday and ended their trading session on a negative note.

Related Views On News

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Nov 20, 2018 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS